VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $526,000 | +45.3% | 22,630 | -0.5% | 0.01% | +18.2% |
Q1 2018 | $362,000 | -23.5% | 22,739 | 0.0% | 0.01% | -21.4% |
Q4 2017 | $473,000 | +25.8% | 22,739 | -13.5% | 0.01% | +27.3% |
Q3 2017 | $376,000 | -17.4% | 26,273 | 0.0% | 0.01% | -26.7% |
Q2 2017 | $455,000 | +55.8% | 26,273 | -0.8% | 0.02% | +66.7% |
Q1 2017 | $292,000 | – | 26,485 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |